DJ Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ shed 2.17% to $131.36 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.25% to 6,373.45 and Dow Jones Industrial Average falling 0.45% to 43,975.09.
The stock's fall snapped a six-day winning streak.
Abbott Laboratories closed 6.99% short of its 52-week high of $141.23, which the company reached on March 4th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.28% to $173.82, Pfizer Inc. $(PFE)$ remained unchanged, and Merck & Co. Inc. $(MRK)$ fell 0.82% to $80.03.
Trading volume (7.1 M) eclipsed its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 11, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments